Audio Seminars

Home | Contact Us | Newsletter | Usersclub | Books | Audio Seminars

All documents shown here are included in the seminar for instant download


1. How much can you change an official methods before it isn't the official method any more 

2. Analytical method validation - A Regulatory Perspective

Verification of Compendial Procedures

Learn from FDA Warning Letters what inspectors look for and what mistakes other companies make so you can avoid them


Labcompliance On-line Audio Seminar

Learn from the convenience of your desk or with your colleagues in a seminar room
(to learn more about audio seminars, click here).
To share this seminar info with your colleagues, click here

On-line Audio Seminar 391

Validation of Analytical Methods According to ICH, USP and FDA Guidelines

Design, Conduct and Document for Efficiency and Compliance

April 12, 2018


Order Button

Analytical methods should be validated to ensure reliability, consistency and accuracy of analytical data. Method validation has been a requirement of FDA and international regulations since many years. Most often the theory is well understood but there are many questions when validation experiments are designed, conducted, and documented.

Key Questions related to Analytical Method Validation are:

  • What are FDA and international requirements?
  • What exactly are the expectations of inspectors?
  • What parameters should be validated?
  • Which acceptance criteria MUST be defined and are acceptance limits?
  • Should standard and compendial methods be validated?
  • Should we re-write compendial methods in SOP format?
  • How to validate bio-analytical methods?
  • What is the difference between accuracy and recovery?
  • What information should be included in regulatory submissions?
  • I want to transfer a method from development to routine lab, do we need to revalidate?
  • We want to transfer to an other site, do we need to revalidate?
  • How to document method validation for the FDA?
  • We have changed our method, should we revalidate?
  • We use software for automated method validation, should it be Part 11 compliant?

How does the audio seminar help:

Answers will be presented by Dr. Ludwig Huber in a new interactive audio seminar. During the seminar, the speaker will present strategies and give practical recommendations. After the seminar, an extensive list of reference material like SOPs, templates and examples will help immediate and cost effective implementation.

During the interactive presentation you learn about:

  • FDA regulations and guidelines
  • Examples of warning letters and how to avoid them
  • USP Chapters and ICH Guides
  • Developing an SOP for method validation
  • Development of a validation plan for success
  • Prerequisites for method validation
  • Defining the minimum number of validation experiments that satisfy ICH, FDA and USP
  • Defining test conditions and acceptance limits
  • Verification of compendial methods
  • To revalidate or not after method changes
  • Transferring a method to routine
  •  Seven most common method validation pitfalls and how to avoid them
  • Using software for automated method validation
  • Documentation for the FDA and for other agencies

And for easy and instant implementation:
download 10+ documents from special seminar website

  • 70 page primer: Validation of Analytical Methods
  • SOPs
    - Validation of Analytical Methods
    - Validation of Chromatographic Methods
    - Verification of Compendial Methods
    - Change versus Adjustment of Compendial Methods
  • Template/Checklist:
    - Validation of Analytical Methods
  • Example
    - Detailed Validation Report
  • Reference Articles
    - Validation of Analytical Methods: Review and Strategy
    - Validation of HPLC methods
    - Evaluation and Validation of Standard Methods
    - Adjusting Conditions for a Routine Reversed-Phase HPLC Assay,
    Part II: Changing Separation Conditions (link)
  • Five Warning letters and/or Inspectional observations related to method validation
  • FDA Guidance and Policy:
    - Requesting Methods Validation for Abbreviated New Drug Applications
    - Bioanalytical Method Validation
    - Analytical Procedures and Methods Validation (draft)
  • FDA presentations on method validation
    - Analytical Methods Validation, A Regulatory Perspective
  • ICH Guidelines for the Industry Q2 (R1)
    - Text and Methodology on Validation of Analytical Procedures

Who should attend?

  • (Bio) Pharmaceutical and API Industry
  • Food, environmental, clinical, and chemical testing laboratories
  • QA managers and personnel
  • Analysts and lab managers
  • Validation specialists
  • Training departments
  • Documentation department
  • Consultants

Date and time

April 12, 2018


North America: ET 11 a.m. (e.g., Washington D.C.), CT 10 a.m. PT 8 a.m.
Europe: CET 5 p.m. (Paris/Berlin)
Check:  for you local time. 

The seminar will last one hour

How to order

Pick one of the options in the table that fits your needs.

Standard offer

  • Single person
  • From the convenience of your desk

US$ 249.-
Order Now Button

'Site' offer

  • Multiple persons - single site and phone line
  • Meet in a seminar or conference room

US$ 399.-
Order Now Button

Recorded seminar - CD

  • Get the CD in your mail
  • Useful if you can/could not attend the on-line seminar. Order includes all reference material.

US$ 399.-
Order Now Button

Recorded seminar - Download Version

  • Download from the Internet
  • Listen and learn whenever you want, wherever you want. Order includes all reference material.

US$ 399.-
Order Now Button

Special offer for Labcompliance Usersclub Members

  • Order includes all reference material.
  • for Usersclub information and registration, click here

from US$ 149.-
Order Now Button

About audio seminars


Online audio seminars are presented over the phone. During the live presentation attendees can:

  1. Study the printed slide material
  2. Watch the slides on a computer
  3. Watch the slides on a video screen in a seminar room
  4. Ask questions through email and web form

About Dr. Ludwig Huber

Dr. Ludwig Huber is the editor and author of Labcompliance. He has been conducting over 300 web and audio or video based seminars since 15 years and and he has given multiple presentations mainly on GLP/GMP, 21 CFR Part 11 and Validation around the world. This included seminars, workshops and presentations for the US FDA, SFDA, KFDA, HSA, ISPE, PDA, PIC/S and several national health agencies.

Dr. Ludwig Huber is a frequent presenter at IVT conferences and has been awarded as the 'Presenter of the Year' out of 170 speakers. This photo is from IVT's conference on Network Qualification with Ludwig Huber as plenary speaker.

Dr. Huber has published several books related to validation and compliance, for example: Validation of Computerized Analytical and Networked Systems. He was or still is a member of several committees, e.g., of the GAMP® Special interest group (SIG) on Laboratory Computers, PDA Part 11 task force, IVT task force on network infrastructure qualification and the European Compliance Academy. He frequently visited FDA in Rockville, VA, and participated in panel discussions with FDA professionals. For feedback from attendees of seminars and  for other information on Dr. Ludwig Huber, click here.

Dr. Ludwig Huber in Panel Discussions with FDA Officials

George Smith, FDA's national Part11 expert, at a panel discussion with Ludwig Huber during an IVT conference

Smith and Huber discussed and answered questions about computer system validation and e-records.
Ludwig Huber (right) and John Murray, FDA's Computer Validation Expert, (left), speaking at the IVT Computer System Validation Conference.
Mr. Murray explained FDA's next steps for Part 11

Ludwig Huber (right) in a panel discussion with FDA inspectors and directors:
 Dr. Robert C. Horan, B Erik Henrikson,Joseph Famulare,  and Nicholas Buhay,